A single treatment can offer a temporary boost, but sustained benefits require repeated dosing that keeps plasma concentrations elevated over time
Key dates: TRIUMPH-1 and TRIUMPH-2 results (mid-2026), head-to-head vs tirzepatide (December 2026), and any NDA filing announcement from Eli Lilly
For more strategies to afford prescriptions, call your SHIP (shiphelp.org) or Medicare Rights free, national helpline at 800-333-4114
Clinical Implications of the 7-Day Half-Life The seven-day half-life has several important clinical implications beyond just dosing convenience
We do not treat varicose veins
According to Hamlet Gasoyan, PhD, MPH, a researcher at Cleveland Clinic, being on a diabetes medication can sometimes lead to weight gain